Use of levodopa, carbidopa and entacapone for treating Parkinson's disease

Details for Australian Patent Application No. 2011222856 (hide)

Owner Orion Corporation

Inventors Rouru, Juha; Kuoppamaki, Mikko; Ellmen, Juha; Mannisto, Pekka

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2011222856

PCT Pub. Number WO2011/107653

Priority 61/310,398 04.03.10 US; 61/438,416 01.02.11 US; 61/412,821 12.11.10 US

Filing date 3 March 2011

Wipo publication date 9 September 2011

International Classifications

A61K 9/00 Medicinal preparations characterised by special physical form

A61K 9/20 Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/28 Medicinal preparations characterised by special physical form - Dragees

A61K 31/198

A61K 31/275 - Nitriles

A61K 45/06 Medicinal preparations containing active ingredients not provided for in groups

A61P 25/16 Drugs for disorders of the nervous system

Event Publications

26 July 2012 PCT application entered the National Phase

  PCT publication WO2011/107653 Priority application(s): WO2011/107653

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011222860-A probe indicating intermaterial boundaries

2011222850-Non-invasive sensor for determining functional characteristics of the cornea, device including said sensor and use thereof